Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro assays used to measure the activity of topoisomerases.

Literature DB >> 2158270

In vitro assays used to measure the activity of topoisomerases.

J F Barrett¹, J A Sutcliffe, T D Gootz.

Abstract

Mesh：

Substances：

Year: 1990 PMID： 2158270 PMCID： PMC171509 DOI： 10.1128/AAC.34.1.1

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

× No keyword cloud information.

96 in total

Review 1. Biology of bacterial deoxyribonucleic acid topoisomerases.

Authors: K Drlica
Journal: Microbiol Rev Date: 1984-12

2. Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

Authors: G L Chen; L Yang; T C Rowe; B D Halligan; K M Tewey; L F Liu
Journal: J Biol Chem Date: 1984-11-10 Impact factor: 5.157

3. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.

Authors: A Minocha; B H Long
Journal: Biochem Biophys Res Commun Date: 1984-07-18 Impact factor: 3.575

4. HMG17 protein facilitates the DNA catenation reaction catalyzed by DNA topoisomerases.

Authors: Y C Tse; K Javaherian; J C Wang
Journal: Arch Biochem Biophys Date: 1984-05-15 Impact factor: 4.013

5. Potent catenation of supercoiled and gapped DNA circles by topoisomerase I in the presence of a hydrophilic polymer.

Authors: R L Low; J M Kaguni; A Kornberg
Journal: J Biol Chem Date: 1984-04-10 Impact factor: 5.157

6. A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma.

Authors: G F Riou; M Gabillot; M Barrois; F Breitburd; G Orth
Journal: Eur J Biochem Date: 1985-02-01

7. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs is DNA.

Authors: L L Shen; A G Pernet
Journal: Proc Natl Acad Sci U S A Date: 1985-01 Impact factor: 11.205

8. Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

Authors: B D Halligan; K A Edwards; L F Liu
Journal: J Biol Chem Date: 1985-02-25 Impact factor: 5.157

9. Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

Authors: E M Nelson; K M Tewey; L F Liu
Journal: Proc Natl Acad Sci U S A Date: 1984-03 Impact factor: 11.205

10. Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II.

Authors: D K Trask; J A DiDonato; M T Muller
Journal: EMBO J Date: 1984-03 Impact factor: 11.598

12 in total

Review 1. Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems.

Authors: T D Gootz; J F Barrett; J A Sutcliffe
Journal: Antimicrob Agents Chemother Date: 1990-01 Impact factor: 5.191

Review 2. Topoisomerase I in multiple drug resistance.

Authors: A Pessina
Journal: Cytotechnology Date: 1993 Impact factor: 2.058

Review 3. A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors: Gregory S Bisacchi; Michael R Hale
Journal: Curr Med Chem Date: 2016 Impact factor: 4.530

4. The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.

Authors: Elisabeth J Walsby; Steven J Coles; Steven Knapper; Alan K Burnett
Journal: Haematologica Date: 2010-12-06 Impact factor: 9.941

5. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.

Authors: Jacob Strahilevitz; David C Hooper
Journal: Antimicrob Agents Chemother Date: 2005-05 Impact factor: 5.191

6. Novel quinolone resistance mutations of the Escherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins.

Authors: P Hallett; A Maxwell
Journal: Antimicrob Agents Chemother Date: 1991-02 Impact factor: 5.191